Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.110
-0.120 (-2.84%)
At close: Apr 17, 2026, 4:00 PM EDT
4.058
-0.052 (-1.27%)
After-hours: Apr 17, 2026, 7:41 PM EDT
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 17 or -42.50% compared to the previous year.
Employees
23
Change
-17
Growth
-42.50%
Revenue / Employee
$310,652
Profits / Employee
-$895,478
Market Cap
193.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 23 | -17 | -42.50% |
| Sep 30, 2025 | 22 | -31 | -58.49% |
| Jun 30, 2025 | 21 | -49 | -70.00% |
| Mar 31, 2025 | 18 | -57 | -76.00% |
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Sep 30, 2024 | 53 | -35 | -39.77% |
| Jun 30, 2024 | 70 | -19 | -21.35% |
| Mar 31, 2024 | 75 | -5 | -6.25% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Sep 30, 2023 | 88 | 12 | 15.79% |
| Jun 30, 2023 | 89 | 22 | 32.84% |
| Mar 31, 2023 | 80 | 26 | 48.15% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Sep 30, 2022 | 76 | 55 | 261.90% |
| Jun 30, 2022 | 67 | 57 | 570.00% |
| Mar 31, 2022 | 54 | 44 | 440.00% |
| Dec 31, 2021 | 39 | 31 | 387.50% |
| Sep 30, 2021 | 21 | 13 | 162.50% |
| Mar 31, 2021 | 10 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Karyopharm Therapeutics | 228 |
| Protalix BioTherapeutics | 226 |
| Heron Therapeutics | 128 |
| Nkarta | 108 |
| Agenus | 81 |
| Corbus Pharmaceuticals Holdings | 36 |
| Enlivex | 34 |
WHWK News
- 2 days ago - Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series - PRNewsWire
- 8 days ago - Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026 - PRNewsWire
- 4 weeks ago - Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - PRNewsWire
- 5 weeks ago - Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PRNewsWire
- 7 weeks ago - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - PRNewsWire
- 3 months ago - Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 - PRNewsWire
- 4 months ago - Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - PRNewsWire